Detalhe da pesquisa
1.
Hypoxia-inducible factor 1A inhibition overcomes castration resistance of prostate tumors.
EMBO Mol Med
; 15(6): e17209, 2023 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37070472
2.
Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant progression.
Sci Adv
; 8(29): eabo2295, 2022 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867798
3.
Single-cell analyses unravel cell type-specific responses to a vitamin D analog in prostatic precancerous lesions.
Sci Adv
; 7(31)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34330705
4.
Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation.
Gynecol Oncol Rep
; 33: 100600, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32613071
5.
[Hope for a new treatment for castration-resistant prostate cancer]. / Espoir d'un nouveau traitement pour le cancer de la prostate résistant à la castration.
Med Sci (Paris)
; 39(10): 709-711, 2023 10.
Artigo
em Francês
| MEDLINE | ID: mdl-37943128
6.
PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo.
J Exp Med
; 215(6): 1749-1763, 2018 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29743291